Clec4g (LSECtin) interacts with BACE1 and suppresses Aβ generation

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (Aβ) peptides.
• Beta-site amyloid precursor protein cleaving enzyme-1 (BACE1) is crucial for Aβ production.
• Targeting BACE1 is a potential therapeutic strategy for AD.

Purpose of the Study:

• To investigate the role of C-type lectin-like domain family 4, member g (Clec4g) in BACE1-mediated amyloid-beta generation.
• To identify novel modulators of BACE1 activity for Alzheimer's disease therapy.

Main Methods:

• Co-immunoprecipitation assays to detect BACE1-Clec4g interaction in mouse brain and cultured cells.
• Western blotting and ELISA to quantify Aβ levels.
• Immunofluorescence microscopy to analyze BACE1 intracellular distribution.

Main Results:

• Clec4g was found to interact with BACE1 in both mouse brain and cultured cells.
• Overexpression of Clec4g significantly suppressed BACE1-mediated Aβ generation.
• Clec4g affected the intracellular distribution of BACE1 without altering its catalytic activity.

Conclusions:

• Clec4g negatively regulates BACE1 function by modulating its intracellular distribution.
• Clec4g represents a novel therapeutic target for Alzheimer's disease by controlling Aβ production.